VISIT US IN CHICAGO JUNE 2-4 AT BOOTH 2073!

Search Videos by Topic or Participant
Browse by Series:

Adjuvant Versus Neoadjuvant Chemotherapy for NSCLC

Benjamin P. Levy, MD
Published: Tuesday, Dec 02, 2014
For High-Definition, Click
For patients with NSCLC undergoing surgical resection with curative intent, clinical trials have demonstrated that adjuvant cisplatin-based chemotherapy prolongs life and improves other outcomes, notes Benjamin P. Levy, MD. Chemotherapy may be administered after surgery (adjuvant chemotherapy) or before surgery (neoadjuvant chemotherapy).

The results of meta-analyses have demonstrated that outcomes with neoadjuvant chemotherapy are similar to outcomes with adjuvant chemotherapy. There are theoretical benefits associated with a neoadjuvant approach, comments Levy. For example, with a neoadjuvant approach, patients may be more likely to complete all 4 planned cycles of chemotherapy, whereas it may be more challenging for patients to complete all 4 cycles of chemotherapy after surgery. Levy adds that at his practice site, clinicians generally rely on adjuvant chemotherapy.
Slider Left
Slider Right
For High-Definition, Click
For patients with NSCLC undergoing surgical resection with curative intent, clinical trials have demonstrated that adjuvant cisplatin-based chemotherapy prolongs life and improves other outcomes, notes Benjamin P. Levy, MD. Chemotherapy may be administered after surgery (adjuvant chemotherapy) or before surgery (neoadjuvant chemotherapy).

The results of meta-analyses have demonstrated that outcomes with neoadjuvant chemotherapy are similar to outcomes with adjuvant chemotherapy. There are theoretical benefits associated with a neoadjuvant approach, comments Levy. For example, with a neoadjuvant approach, patients may be more likely to complete all 4 planned cycles of chemotherapy, whereas it may be more challenging for patients to complete all 4 cycles of chemotherapy after surgery. Levy adds that at his practice site, clinicians generally rely on adjuvant chemotherapy.
View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Oncology Briefings™: Updates in Novel Therapeutic Options for Lung Neuroendocrine TumorsMay 31, 20181.0
Community Practice Connections™: Working Group to Optimize Outcomes in EGFR-mutated Lung Cancers: Evolving Concepts for Nurses to Facilitate and Improve Patient CareJun 30, 20181.5
Publication Bottom Border
Border Publication
x